Catheter Precision (VTAK) Treasury Shares (2018 - 2025)

Catheter Precision (VTAK) posted quarterly Treasury Shares of $6000.0 for Q3 2025, down 88.0% quarter-over-quarter from $50001.0 in Q1 2025.

Catheter Precision (VTAK) Treasury Shares (2018 - 2025) Analysis & Trends

Catheter Precision (VTAK) has reported Treasury Shares for 7 consecutive years, with $6000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Treasury Shares changed N/A year-over-year to $6000.0; the TTM figure through Sep 2025 stood at $6000.0 (changed N/A YoY), while the FY2023 annual figure was $140.8 million, up 230845801.64% from the prior year.
Treasury Shares eased to $6000.0 in Q3 2025 per VTAK's latest filing, from $50001.0 in the prior quarter.
Across five years, Treasury Shares topped out at $753.7 million in Q3 2023 and bottomed at $61.0 in Q4 2022.
Historically, Treasury Shares has averaged $68.9 million across 4 years, with a median of $50001.0 in 2025.
Annual changes were most pronounced in 2022 — Treasury Shares tumbled 99.56% — and 2023, when it jumped 230845801.64%.
Catheter Precision's Treasury Shares stood at $3586.0 in 2021, then slumped by 98.3% to $61.0 in 2022, then surged by 230845801.64% to $140.8 million in 2023, then slumped by 100.0% to $6000.0 in 2025.
Business Quant data shows VTAK's Treasury Shares at $6000.0 in Q3 2025, $50001.0 in Q1 2025, and $140.8 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	267.91 Mn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	-
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	-
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	303.21 Mn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	85.10 Mn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	2.73 Bn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	525.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	16.27 Mn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	-
10	Catheter Precision	570,646.14	-1.27 Mn	98,000.00	-

Download Data